The Proderm Technology Foam Delivery System consists of a unique chemical structure that facilitates superior
penetration of drug ingredients into the dermal layer with a cosmetically elegant feel. The intellectual
property underlying the Transdermal System is patent protected under U.S. Patent 5,993,830.
Quinnova is conducting development work on dermal foam products for the treatment of dermitis, inflammation, and Tinea Versicolor.